Neutrophils and Platelets: Why Are They Monitored So Closely?
Why are neutrophils and platelets monitored so closely? Andrew Schorr, Patient Power founder and host, poses this question to Drs. William Wierda... Learn More
Novartis Access – measuring the impact
Professor Richard Laing, an expert on access-to-medicine programs, says the pharma industry needs to better measure the impact of our programs. So... Learn More